Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. [electronic resource]
Producer: 19930226Description: 38-42 p. digitalISSN:- 0007-1250
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.